p53 point mutations and thymidylate synthase messenger RNA levels in disseminated colorectal cancer: An analysis of response and survival

Clinical Cancer Research

Volumn 4, Issue 5, 1998, Pages 1243-1250

  Lenz, Heinz Josef ^a   Hayashi, Kazuhiko ^a   Salonga, Dennis ^a   Danenberg, Kathleen D ^a   Danenberg, Peter V ^a   Metzger, Ralf ^a   Banerjee, Debabrata ^b   Bertino, Joseph R ^b   Groshen, Susan ^a   Leichman, Lawrence P ^a   Leichman, Cynthia G ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; MESSENGER RNA; PROTEIN P53; THYMIDYLATE SYNTHASE;

ADULT; AGED; ARTICLE; CANCER GENETICS; CANCER SURVIVAL; CLINICAL ARTICLE; COLORECTAL CANCER; DRUG RESPONSE; FEMALE; HUMAN; MALE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; GENES, P53; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; POINT MUTATION; RNA, MESSENGER; SURVIVAL ANALYSIS; THYMIDYLATE SYNTHASE;

EID: 14444285483     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Moertel, C. G. Chemotherapy for colorectal cancer. N. Engl. J. Med., 330: 1136-1143, 1994.
2. Grem, J. L. 5-Fluorouracil plus leucovorin in cancer therapy. In: V. T. De Vita, Jr., S. Hellman, and S. A. Rosenberg (eds.), Principles and Practice of Oncology Update Series, Vol. 2, No. 7. Philadelphia: J. B. Lippincott, 1988.
3. Berger, S. H., Jeng, C-H., Johnson, L. F., and Berger, F. G. Thymidylate synthase overproduction and gene amplification in fluorode-oxyuridine-resistant human cells. Mol. Pharmacol., 28: 461-467, 1985.
4. Danenberg, K. D., and Danenberg, P. V. Activity of thymidylate synthase and its inhibition by 5-fluorouracil in highly enzyme-overproducing cells resistant to 10-propargyl-5,8-dideazafolate. Mol. Pharmacol., 36: 219-223, 1989.
5. Spears, C. P., Gustavson, B. G., Berne, M., Frosing, R., Bernstein, L., and Hayes, A. A. Mechanism of innate resistance to thymidylate synthase inhibition after 5-fluorouracil. Cancer Res., 48: 5894-5900, 1988.
6. Leichman, C. G., Lenz, H-J., Leichman, L., Danenberg, K. D., Baranda, J., Groshen, S., Boswell, W., Danenberg, P. V. Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted infusion 5-fluorouracil and weekly leucovorin. J. Clin. Oncol., 75: 3223-3229, 1997.
7. Lenz, H-J., Leichman, C. G., Danenberg, K. D., Danenberg, P. V., Groshen, S., Cohen, H., Laine, L., Crookes, P., Silberman, H., Baranda, J., Garcia, Y., Li, J., and Leichman, L. Thymidylate synthase expression in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survival. J. Clin. Oncol., 14: 176-182, 1996.
8. Leichman, L., Lenz, H-J., Leichman, C. G., Groshen, S., Danenberg, K., Baranda, J., Spears, C. P., Boswell, W., Silberman, H., Ortega, A., Stain, S., Beart, R., and Danenberg, P. Quantitation of intratumoral thymidylate synthase expression predicts for resistance to protracted infusion of 5-fluorouracil and weekly leucovorin in disseminated colorectal cancers: preliminary report from an ongoing trial. Eur. J. Cancer, 31: 1306-1310, 1995.
9. Johnston, P. G., Lenz, H-J., Leichman, C. G., Danenberg, K. D., Allegra, C. J., Danenberg, P. V., and Leichman, L. Thymidylate synthase protein and gene expression predicts for response to 5-fluorouraciul, leucovorin in patients with colorectal and gastric cancer. Cancer Res., 55: 1407-1412, 1995.
10. Lowe, S. W., Ruley, H. E., Jacks, T., and Housman, D. E. p53 dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74: 957-967, 1993.
11. Lowe, S. W., Bodis, S., McClatchey, A., Remington, L., Rully, H. E., Fisher, D. E., Housman, D. E., and Jacks, T. p53 status and the efficacy of cancer therapy in vivo. Science (Washington DC), 266: 807-810, 1994.
12. Fujiwara, T., Grimm, E. A., Mukhopadhyay, T., Zhang, W. W., Owen-Schaub, L. B., and Roth, J. A. Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene. Cancer Res., 54: 2287-2291, 1994.
13. Lane, D. P. Cancer. A death in the life of p53. Nature (Lond.), 362: 786-787,1993.
14. Fisher, D. E. Apoptosis in cancer therapy, crossing the threshold. Cell, 78: 539-542, 1994.
15. Kastan, M. B., Onyekwere, O., Sidransky, D., Vogelstein, B., and Craig, R. W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51: 6304-6311, 1991.
16. Aas, T., Børresen, A-L., Geisler, S., Smith-Sørensen, B., Johnsen, H., Varhaug, J. E., Akslen, L. A., and Lønning, P. E. Specific p53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients. Nat. Med., 7: 811-814, 1996.
17. Børresen, A. L., Andersen, T. I., Eyjord, J. E., Cornelis, R. S., Thorlacius, S., Borg, A., Johansson, U., Theillet, C., Scherneck, S., Hartman, S. Tp53 mutations and breast cancer prognosis: particularly poor survival rates for cases with mutations in the zinc binding domains. Genes Chromosomes Cancer, 14: 71-75, 1995.
18. Goh, H. S., Yao, J., and Smith, D. R. p53 point mutation and survival in colorectal cancer patients. Cancer Res., 55: 5217-5221, 1995.
19. Cho, Y., Gorina, S., Jeffrey, P. D., Pavletich, N. P., Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science (Washington DC), 265: 334-335, 1994.
20. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyabate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
21. Horikoshi, T., Danenberg, K. D., Stadibauer, T. H. W., Volkenandt, M., Shea, L. C. C., Aigner, K., Gustavsson, B., Leichman, L., Frosing, R., Ray, M., Gibson, N. W., Spears, C. P., and Danenberg, P. V. Quantitation of thymidylate synthase, dihydrofolate reductase, and DT-diaphorase gene expression in human tumors using the polymerase chain reaction. Cancer Res., 52: 108-116, 1992.
22. Takeishi, K., Kaneda, S., Ayusawa, D., Shimizu, K., Gotoh, O., and Seno, T. Nucleotide sequence of a functional cDNA for human thymidylate synthase. Nucleic Acids Res., 13: 2035-2045, 1987.
23. Ng, S-Y., Gunning, P., Eddy, R., Ponte, P., Leavitt, J., Shows, T., and Kedes, L. Evolution of the functional human β-actin gene and its multip-seudogene family: conservation of non-coding regions and chromosomal dispersion of pseudogenes. Mol. Cell. Biol., 5: 2720-2732, 1985.
24. Murray, V. Improved double stranded DNA sequencing using the linear polymerase chain reaction. Nucleic Acids Res., 17: 8889, 1989.
25. Baas, T. O., Mulder, J. W., Offerhaus, G. J., Vogelstein, B., and Hamilton, S. R. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J. Pathol., 172: 5-12, 1994.
26. 2 statistics. Biometrics, 38: 1011-1016, 1982.
27. 2 statistics for small samples. Biometrics, 38: 1017-1023, 1982.
28. Miller, C. W., Chumakow, A., Said, J., Chen, D. L., Aslo, A., and Koeffler, H. P. Mutant p53 proteins have diverse intracellular abilities to oligomerize and activate transcription. Oncogene, 8: 1815-1824, 1993.
29. Park, D. J., Nakamura, H., Chumakov, A. M., Said, J. W., Miller, C. W., Chen, D. L., and Koeffler, H. P. Transactivational and DNA binding abilities of endogenous p53 in p53 mutant cell lines. Oncogene, 9: 1899-1906, 1994.
30. Harpole, D. H., Herndon, J. E., Wolfe, W. G., Iglehart, J. D., and Marks, J. R. A prognostic model of recurrence and death in stage I non-small lung cancer utilizing presentation, histopathology and oncoprotein expression. Cancer Res., 55: 51-56, 1995.
31. Isobe, T., Hiyama, K., Yoshida, Y., Fujiwara, Y., and Yamakido, M. Prognostic significance of p53 and ras gene abnormalities in lung adenocarcinoma patients with stage I disease after curative resection. Jpn. J. Cancer Res., 85: 1240-1246, 1994.
32. Hsiao, M. H., Yu, A. L., Yeargin, J., Ku, D., and Haas, M. Nonhereditary p53 mutations in T-cell acute lymphoblastic leukemia are associated with the relapse phase. Blood, 83: 2922-2930, 1994.
33. Allred, D. G., Clark, G. M., Elledge, R., Fuqua, S. A. W., Brown, W., Chamness, G. C., Osborne, C. K., and McGuire, W. L. Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J. Natl. Cancer Inst., 85: 200-206, 1993.
34. Silvestrini, R., Benini, E., Daidone, M. G., Veneroni, S., Boracchi, P., Cappelletti, V., Di Fronzo, G., and Veronesi, U. p53 as an independent prognostic marker in lymph node-negative breast cancer patients. J. Natl. Cancer Inst., 85: 965-970, 1993.
35. Esrig, D., Elmajian, D., Groshen, S., Freeman, J. A., Stein, J. P., Chen, S. C., Nichols, P. W., Skinner, D. G., Jones, P. A., and Cote, R. J. Accumulation of nuclear p53 and tumor progression in bladder cancer. N. Engl. J. Med., 331: 1259-1264, 1994.
36. Yoshimura, I., Kudoh, J., Saito, S., Tazaki, H., and Shimizu, N. p53 gene mutation in recurrent superficial bladder cancer. J. Urol., 153: 1711-1715, 1995.
37. Yamaguchi, A., Nakagawara, G., Kurosaka, Y., Nishimura, G., Yonemura, Y., and Miyazaki, I. p53 immunoreaction in endoscopic biopsy specimens of colorectal cancer and its prognostic significance. Br. J. Cancer, 68: 399-402, 1993.
38. Bosari, S., Viale, G., Bossi, P., Maggioni, M., Coggi, G., Myrray, J. J., Lee, A. K. C. Cytoplasmatic accumulation of p53: an independent prognostic indicator in colorectal adenocarcinomas. J. Natl. Cancer Inst., 86: 681-687, 1994.
39. Sun, X-F., Carstensen, J. M., Zhang, H., Stal, O., Wingren, S., Hatschek, T., and Nordenskjold, B. Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma. Lancet, 340: 1369-1373, 1992.
40. Lenz, H-J., Danenberg, K. D., Leichman, C. G., Florentine, B., Johnston, P. G., Groshen, S., Danenberg, P. V., and Leichman, L. P. p53 and thymidylate expression are associated and predict for tumor recurrence in patients with stage II colon cancer. Proc. Am. Soc. Clin. Oncol., 15: 501, 1996.
41. Chu, E., Copur, S., Jones, K. L., Khleif, S., Voeller, D., Maley, G. F., Maley, F., and Allegra. C. J. Thymidylate synthase regulates the translation of p53 mRNA. Proc. Am. Assoc. Cancer Res., 36: 563, 1995.